fianlimab,cemiplimab
regeneron,sanofi
['fianlimab', 'agent', 'cemiplimab', 'medsir']
data of first-in-human ph1 study of fianlimab + cemiplimab expansion cohorts in pts with adv. mel. meaningful clinical act. was observed in pts with anti-pd-(l)1-na ve (orr 63.8%; mdor nr; mpfs estimated 24mo). safety profile was similar to anti-pd-1 agents. #esmo22 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM